SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: gg cox who wrote (13678)10/5/2004 11:16:46 AM
From: VAUGHN   of 14101
 
Hello ggc

Politely put, that was also the general opinion of the author of the letter to the editor.

Here is another Cannacord Morning Coffee quote raising a nice possibility:

Dimethaid Research (DMX: TSX: $0.95), Net Change: 0.15, % Change: 18.75%, Volume: 8,059,100

The painless hand wriggling continued after the amazing move last Friday, when the Journal of Rheumatology published a fantastic clinical study that demonstrates that the anti-arthritic lotion Pennsaid is safer than pills containing the same active ingredient. Plus, Pennsaid works just as well as the maximum daily dose of comparable oral medication at relieving knee osteoarthritis symptoms. With US$2.5 billion worth of annual Vioxx sales up in the air, Dimethaid is bound to see some of it. At least in theory. The problem has always been that Dimethaid has been next to totally inept at selling their wonderful product.

In other words, it is an inept sales force that is the problem and not the product. Will the company fix this problem? Maybe. We don’t see why Merck (MRK) doesn’t just buy this thing. “Sorry ‘bout the Vioxx but check this out...”


That would be nice (a buyout from Merck)

Regards

Vaughn

P.S. Looks as if the shorts are doing their best again. It would be lovely to see them get burned just once...
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext